Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Diagn Cytopathol ; 16(6): 526-30, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9181320

ABSTRACT

Salivary duct carcinoma is a high grade malignancy which histologically strongly resembles ductal carcinoma of the breast. The findings from five cases of histologically proven salivary duct carcinoma sampled by preoperative fine-needle aspiration (FNA) cytology are presented. Characteristic cytomorphologic features include cohesive clusters and flat sheets of epithelial cells which display a cribriform pattern with eccentrically located, hyperchromatic nuclei, abundant finely granular cytoplasm, and necrosis in the smear background.


Subject(s)
Carcinoma/pathology , Salivary Gland Neoplasms/pathology , Aged , Biopsy, Needle , Diagnosis, Differential , Female , Humans , Male , Middle Aged
2.
Am J Obstet Gynecol ; 177(6): 1458-64, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9423751

ABSTRACT

OBJECTIVE: We evaluated subtle endometrial morphologic changes in postmenopausal women assigned to placebo, raloxifene hydrochloride 200 or 600 mg/day, or conjugated estrogens (Premarin 0.625 mg/day) according to a new estrogenicity scoring system. Raloxifene, a new selective estrogen receptor modulator, was not expected to stimulate the endometrium. STUDY DESIGN: Baseline and end point endometrial biopsies were performed during this double-blind, placebo-controlled 8-week study. A scoring system that was based on standard glandular and stromal morphologic criteria was used to quantitate estrogen-induced effects. Baseline, end point, and baseline-to-end point changes were analyzed for treatment differences. RESULTS: Treatment groups were similar at baseline with most women showing no estrogenic effects. At end point, statistically significant moderate and marked estrogenic effects were noted in 77% of estrogen-treated women versus 15% of placebo-treated women versus 0% of raloxifene-treated women. CONCLUSIONS: As expected, estrogen treatment stimulated postmenopausal endometrium. In contrast, raloxifene did not induce histopathologic evidence of endometrial stimulation in healthy postmenopausal women.


Subject(s)
Endometrium/drug effects , Estrogen Antagonists/therapeutic use , Piperidines/therapeutic use , Postmenopause/physiology , Biopsy , Double-Blind Method , Endometrium/pathology , Estradiol/blood , Estrogens, Conjugated (USP)/therapeutic use , Female , Humans , Middle Aged , Postmenopause/blood , Raloxifene Hydrochloride , Stimulation, Chemical
3.
Diagn Cytopathol ; 14(1): 43-50, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8834076

ABSTRACT

Diagnostic Cytology Laboratory, Inc., has an outpatient Fine Needle Biopsy Clinic, which evaluated 7,487 fine-needle biopsies (FNB) from January 1989 to February 1992. Two hundred eighty-eight (3.8%) of these specimens were collected from patients 19 years old or younger and this represents the largest study of this population in the scientific literature. The majority of these specimens were obtained from palpable masses in the head and neck region [lymph nodes (58.3%), thyroid (7.6%), and salivary gland (5.2%)] while a smaller number were collected from miscellaneous soft tissue (18.8%) and breast masses (10.1%). Thirteen (4.5%) (from 12 patients) were diagnosed as malignant by FNB and 275 (95.5%) (264 patients) were benign by FNB. This benign:malignant ratio (22:1) is significantly higher than has been reported from tertiary care institutions and is a reflection of the difference of this outpatient population. Two hundred nine of 276 patients (75.7%) had adequate follow-up, including 137 (49.6%) patients followed by observation, 48 (17.4%) patients followed by surgical biopsy, and 24 (8.7%) patients followed by some other modality: imaging studies, flow cytometry, or treatment. There was a single false positive diagnosis (a pilomatrixoma) and one (1) false negative interpretation (a cystic acinic cell carcinoma) resulting in a diagnostic sensitivity of 92.3% and a specificity of 99.6%. The positive predictive value was 92.3%, the negative predictive value was 99.6%, and the test efficiency was 99.3%. The utility, cost-effectiveness and uniqueness of the clinic population is discussed.


Subject(s)
Ambulatory Care , Biopsy, Needle , Breast Diseases/pathology , Lymph Nodes/pathology , Salivary Gland Diseases/pathology , Soft Tissue Neoplasms/pathology , Thyroid Diseases/pathology , Adolescent , Adult , Child , Child, Preschool , False Positive Reactions , Female , Follow-Up Studies , Humans , Infant , Male
4.
J Perinatol ; 9(2): 159-61, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2661761

ABSTRACT

A term newborn with Candida albicans infection of the lungs and blood is described. Although no maternal risk factors were identified, this patient's rapid clinical deterioration and postmortem findings suggest congenital infection. Related cases in the literature are reviewed. This case suggests that a diagnosis of fungal pneumonia should be considered in any infant presenting with severe respiratory distress.


Subject(s)
Candidiasis/congenital , Lung Diseases, Fungal/congenital , Pneumonia/congenital , Adult , Candidiasis/blood , Female , Humans , Infant, Newborn , Pregnancy , Respiratory Distress Syndrome, Newborn/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...